Profil
Hui Ping Jiang is currently the Chief Regulatory Officer at Valerio Therapeutics SA. Previously, she held the position of President & Director at Qx Therapeutics, Inc. and Senior Vice President & Head-Regulatory Affairs at Epizyme, Inc. She holds a doctorate degree from Clarkson University and an undergraduate degree from Nanjing University.
Postes actifs de Hui Ping Jiang
| Sociétés | Poste | Début |
|---|---|---|
| VALERIO THERAPEUTICS | Conseiller Juridique Général | - |
Anciens postes connus de Hui Ping Jiang
| Sociétés | Poste | Fin |
|---|---|---|
Qx Therapeutics, Inc. | President | - |
| EPIZYME, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Hui Ping Jiang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Valerio Therapeutics SA
Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Clarkson University
Clarkson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Qx Therapeutics, Inc. |
















